CLONAZEPAM - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN EPILEPSY

被引：112

作者：

PINDER, RM ^{[1
]}

BROGDEN, RN ^{[1
]}

SPEIGHT, TM ^{[1
]}

AVERY, GS ^{[1
]}

机构：

[1] AUSTRALASIAN DRUG INFORMATION SERV, Auckland 10, NEW ZEALAND

来源：

DRUGS | 1976年 / 12卷 / 05期

关键词：

SUBCORTICAL EPILEPTOGENIC TISSUES; BENZODIAZEPINE RO 5-4023; CLINICAL-EXPERIENCE; STATUS EPILEPTICUS; ANTICONVULSANT PROPERTIES; ANTIEPILEPTIC PROPERTIES; RO-5-4023; CLONAZEPAM; INFANTILE SPASMS; 5-HT METABOLISM; TONIC STATUS;

D O I：

10.2165/00003495-197612050-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：321 / 361

页数：41

共 124 条

[61] ALTERED 5-HT METABOLISM WITH CLONAZEPAM, DIAZEPAM AND DIPHENYLHYDANTOIN [J].

JENNER, P ;

CHADWICK, D ;

REYNOLDS, EH ;

MARSDEN, CD .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (09) :707-710

[62] PHARMACOKINETIC PROFILES OF CLONAZEPAM IN DOG AND HUMANS AND OF FLUNITRAZEPAM IN DOG [J].

KAPLAN, SA ;

ALEXANDER, K ;

JACK, ML ;

PUGLISI, CV ;

DESILVA, JAF ;

LEE, TL ;

WEINFELD, RE .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (04) :527-532

[63]

KETZ E, 1973, SCHWEIZ MED WSCHR, V103, P1134

[64]

KETZ E, 1973, ACTA NEUROL SCAND, V49, P47

[65]

KICK H, 1973, ACTA NEUROL SCAND, V49, P54

[66]

KICK H, 1971, EPILEPSIE, P30

[67]

KNOP HJ, 1975, PHARMACEUTISCH WEEKB, V110, P297

[68]

KRUSE R, 1973, ACTA NEUROL SCAND, V49, P60

[69]

LAITINEN L, 1973, ACTA NEUROL SCAND, V49, P72

[70]

LANCE J W, 1975, Proceedings of the Australian Association of Neurologists, V12, P55

← 2 3 4 5 6 7 8 9 10 11 →